are crucial to optimizing empirical therapy, improving clinical outcomes, and curbing the acceleration of
antimicrobial resistance in the region.
CONCLUSION:
The Medicine Department contributed the largest sample load in 2024, with E. coli emerging as the
predominant isolate. The organism retained high susceptibility to carbapenems, piperacillin–tazobactam, and
fosfomycin, but showed poor response to fluoroquinolones and ampicillin. Department-specific antibiograms
thus remain invaluable for guiding empirical therapy and should be routinely disseminated to treating
physicians to optimize antibiotic selection. For uncomplicated UTIs, oral agents such as fosfomycin and
nitrofurantoin should be prioritized, while carbapenems must be preserved for resistant or severe infections to
prevent the acceleration of antimicrobial resistance.
REFERENCES
1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology,
mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–84.
2. Gupta K, Trautner BW. Urinary tract infections, pyelonephritis, and prostatitis. In: Bennett JE,
Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious
Diseases. 9th ed. Elsevier; 2020. p. 886–913.
3. Nazir A, Kanth F. Bacteriological profile and antimicrobial susceptibility pattern of patients with
urinary tract infections in a tertiary care hospital in a tertiary care center. Journal of Research in
Applied and Basic Medical Sciences 2024; 10 (2) :110-120
4. Sánchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary
Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents
Chemotherapy. 2012;56(4):2181–3.
5. Gandra S, Joshi J, Trett A, Lamkang AS, Laxminarayan R. Scoping report on antimicrobial
resistance in India. Washington, DC: Center for Disease Dynamics, Economics & Policy; 2017.
6. J G Collee, A G Fraser, B P Marimon, A Simmons. . Laboratory strategy in the diagnosis of infective
syndrome: Urinary tract infection. Mackey& McCartney practical medical microbiology 1999.
7. M Cheesebrough. Examination of Urine. District laboratory practicein tropical countries. Part
II 2000
8. B A Forbes, D F Sahm, A S Weissfeld. . Infection of urinary tract. Bailey and scott’s diagnostic
microbiology 2002.
9. S G Gatterman, S P Borriello, P R Murray, G Funke. Bacterial infection of urinary tract. Topley and
wilsonsmicrobiology and microbial infections, Bacteriology 2005.
10. Clinical Laboratory Standards Institute (CLSI) guidelines. Performance standards for antimicrobial
susceptibility testing: Thirty fourth informational supplement. CLSI document M100-S34. Clinical
and Laboratory Standards Institute. Pennsylvania; Wayne; 2024.
11. Rizvi M, Sultan A, Khan F, et al. Regional variations in antimicrobial susceptibility of Escherichia
coli from community-acquired urinary tract infections across India: Results from the ICARE
surveillance network. Indian J Med Microbiol. 2024;42(1):25-33. doi:10.1016/j.ijmmb.2023.10.005
12. Bhargava A, Sharma S, Negi V, et al. Bacteriological profile and antimicrobial resistance pattern of
urinary tract infections in a tertiary care hospital from Northern India. Front Microbiol.
2022;13:965053. doi:10.3389/fmicb.2022.965053
13. Ahirwar N, et al. Prevalence and antimicrobial resistance patterns of uropathogens in suspected
urinary tract infection cases: A retrospective observational study from North India. Med Sci Forum.
2023;24(1):16. doi:10.3390/msf2023024016
14. ICMR-AMRSN Annual Report 2023: Antimicrobial resistance trends among priority pathogens in
India. Indian Council of Medical Research; 202